ID   OCUM-12
AC   CVCL_8380
SY   Osaka City University Medical school-12
DR   Cosmic; 2009532
DR   Wikidata; Q54931822
RX   PubMed=20145613;
RX   PubMed=21115893;
CC   Population: Japanese.
CC   Doubling time: 13.4 hours (Note=At 190th passage) (PubMed=20145613).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C9159; Gastric diffuse adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
RX   PubMed=20145613; DOI=10.1038/sj.bjc.6605543; PMCID=PMC2833244;
RA   Kato Y., Yashiro M., Noda S., Tendo M., Kashiwagi S., Doi Y.,
RA   Nishii T., Matsuoka J., Fuyuhiro Y., Shinto O., Sawada T., Ohira M.,
RA   Hirakawa K.;
RT   "Establishment and characterization of a new hypoxia-resistant cancer
RT   cell line, OCUM-12/Hypo, derived from a scirrhous gastric carcinoma.";
RL   Br. J. Cancer 102:898-907(2010).
//
RX   PubMed=21115893;
RA   Kuramitsu Y., Baron B., Yoshino S., Zhang X.-L., Tanaka T., Yashiro M.,
RA   Hirakawa K., Oka M., Nakamura K.;
RT   "Proteomic differential display analysis shows up-regulation of 14-3-3
RT   sigma protein in human scirrhous-type gastric carcinoma cells.";
RL   Anticancer Res. 30:4459-4465(2010).
//